|
E-Pharma Group, PCAS's (www.pcas.fr) pharmaceutical formulation activity. Dedicated to fulfilling the complete physical products requirements (hardware) of pharmaceutical/neutraceutical firms, from the drug substance to the delivered pack. E PARMA GANNAT is dedicated to solid doses production and to semi-solids. E PHARMA Bessay is dedicated to liquid and topical forms. In 2001: E Pharma Groupe, the holding company, takes control of Creapharm (60 empl.) and Euclidis (15 empl.), both located in Bordeaux (France).
Activity:
- Manufacturing
Product / Technology type(s) covered:
- FP (finished products)
- Pharmaceuticals / Therapeutics
Therapeutic targets:
|
|